United States News Todas as matérias

onsemi (NASDAQ:ON) amended its agreement to acquire Synaptics (NASDAQ:SYNA), switching to a $5.7 billion all-cash purchase at $123 per share.

Aura Minerals (NASDAQ:AUGO) signed a definitive agreement to acquire Newco for R$612 million, or approximately US$118 million, bringing mining fleet operations in-house at three Brazilian gold mines.

Embraer (NYSE:EMBJ) delivered 66 total aircraft during the third quarter of 2026.

Alta Equipment Group (NYSE:ALTG) approved a quarterly preferred stock dividend of $625 per share payable on October 30, 2026.

ACCO Brands Corporation (NYSE:ACCO) officially finalized its acquisition of Netherlands-based computer accessories provider Trust.

Ryanair (NASDAQ:RYAAY) reported a 4% year-over-year increase in September traffic to over 20.1 million passengers.

Johnson & Johnson (NYSE:JNJ) announced Phase 3 clinical results showing sustained skin clearance with ICOTYDE for plaque psoriasis.

TNL Mediagene (NASDAQ:TNMG) signed a definitive agreement to sell its Japanese business for $5.5 million to MI Company, an acquisition vehicle backed by an investor group led by CEO Motoko Imada.

Flowco Holdings (NYSE:FLOC) completed its acquisition of Lifting Solutions Energy Services for approximately US$113 million in cash, expanding its artificial lift portfolio and geographic reach.

Nike (NYSE:NKE) shares fell 8.5% to $32.15 premarket after the sportswear company forecast a high-single-digit fiscal 2027 revenue decline following first-quarter sales of $11.21 billion.

Moderna (NASDAQ:MRNA) shares climbed 2.2% to $193.01 premarket after Nasdaq said the vaccine maker will replace Warner Bros. Discovery (NASDAQ:WBD) in the Nasdaq-100 Index on October 9.

Brent crude fell 0.7% to $101.61 a barrel on Friday while West Texas Intermediate dropped 0.9% to $92.02 as traders weighed improving Middle Eastern supply against geopolitical risks.

Venture Global (NYSE:VG) signed a 20-year sales and purchase agreement with ConocoPhillips (NYSE:COP) to supply 1.0 million tonnes of LNG annually beginning in 2030.

CareTrust REIT (NYSE:CTRE) agreed to acquire 45 U.K. care homes from LNT for about £1.1 billion, including 24 properties acquired for approximately £576 million in the first closing.

Cullinan Therapeutics (NASDAQ:CGEM) initiated an FDA New Drug Application for first-line zipalertinib plus chemotherapy after REZILIENT3 showed a 6.0-month median progression-free survival improvement.

Manulife (NYSE:MFC) completed its previously announced long-term care reinsurance transaction with Munich American Reassurance Company, covering a policy block with C$3.2 billion of reserves.

Ultragenyx (NASDAQ:RARE) announced that the European Medicines Agency validated its marketing authorisation application for investigational gene therapy rebisufligene etisparvovec to treat Sanfilippo syndrome Type A.

Summit Therapeutics (NASDAQ:SMMT) announced a clinical trial collaboration with AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo to evaluate ivonescimab with Datroway in multiple solid tumor settings, including breast and lung cancer.

Shares of major U.S. health insurers moved lower after companies including UnitedHealth Group (NYSE:UNH) and CVS Health (NYSE:CVS) subsidiary Aetna announced their Medicare Advantage plan designs for 2027.

Tesla (NASDAQ:TSLA) registrations increased across several European markets in September, extending a recent recovery in the electric vehicle maker’s regional sales performance.

Arthur J. Gallagher (NYSE:AJG) completed the acquisition of Albany Insurance Services, a New Zealand-based retail insurance brokerage serving commercial and personal insurance clients.

PolyPid (NASDAQ:PYPD) regained exclusive European commercialization rights for D-PLEX₁₀₀ after the company and ADVANZ PHARMA mutually agreed to terminate their 2022 licensing, distribution and supply agreement covering Europe.

Broadcom (NASDAQ:AVGO) has agreed to provide Anthropic with up to $42 billion in financing to support the artificial intelligence company’s infrastructure expansion, according to details from Anthropic’s IPO prospectus reported by Reuters.

Costamare (NYSE:CMRE) declared a quarterly common-stock dividend of $0.125 per share for the quarter ended September 30, 2026.